根据数据统计,2025年3季度,新增968个上市批文,涉及791个品种(药品+企业)。中药领域,三季度获批的中药品种有6个,包括1个1类创新药,5个3.1类古代经典名方。其中,康缘药业的参蒲颗粒为1类创新药,于7月31日获批上市。该产品源自江苏省中医院谈勇教授临床经验方,处方由党参、虎杖、赤芍、蒲公英、大血藤、菝葜、赤芍、延胡索、丹参、乌药、皂角刺等组成,用于治疗盆腔炎性疾病后遗症-慢性盆腔痛(...
Source Link根据数据统计,2025年3季度,新增968个上市批文,涉及791个品种(药品+企业)。中药领域,三季度获批的中药品种有6个,包括1个1类创新药,5个3.1类古代经典名方。其中,康缘药业的参蒲颗粒为1类创新药,于7月31日获批上市。该产品源自江苏省中医院谈勇教授临床经验方,处方由党参、虎杖、赤芍、蒲公英、大血藤、菝葜、赤芍、延胡索、丹参、乌药、皂角刺等组成,用于治疗盆腔炎性疾病后遗症-慢性盆腔痛(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.